USPTO serial 78524381
MEPACT
Reviewed by CopyMark Law Group
Reg. 3116184Status 710
- Filing date
- Status date
- Registration date
- Jul 18, 2006
- Examiner
- FRYE, KIMBERLY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with MEPACT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dennis A. Bennett
Dennis A. Bennett Global Patent Group10411 Clayton RoadSuite 304St. Louis, MO 63131Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the manufacture of preparations for medical or veterinary use, particularly muramyl peptides and muramyl tripeptides, muramyl tripeptide phosphatidyl ethanolamine (MTP-PE), N-acetylmuramyl-L-alanyl-D-isoglutaminyl-L-alanine-2 (1, 2-dipalmitoyl-sn-g lycero-3-hydroxyphosphoryloxy)-ethylamide, hexopyranose and formulations of muramyl peptides, particularly liposomal formulations, pharmaceutically acceptable forms of muramyl peptides, pharmaceutically acceptable salts of muramyl peptides, all of these products being more specifically meant to be used for anti-cancer therapy, antiviral therapy, neoplasia and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy | SECTION 8 - CANCELLED | — |
| 005 | Preparations for medical or veterinary use, particularly muramyl peptides and muramyl tripeptides, muramyl tripeptide phosphatidyl ethanolamine (MTP-PE), N-acetylmuramyl-L-alanyl- D-isoglutaminyl-L-alanine-2 (1, 2-dipalmitoyl-sn-qlycero-3-hydroxyphosphoryloxy)-ethylamide, hexopyranose and formulations of muramyl peptides, particularly liposomal formulations, pharmaceutically acceptable forms of muramyl peptides, and pharmaceutically acceptable salts of muramyl peptides, all of these products being more specifically meant to be used for anti-cancer therapy, antiviral therapy, neoplasia and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy; pharmaceutical preparations for anti-cancer and antiviral therapies, neoplasia, and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by I.D.M. IMMUNO-DESIGNED MOLECULES
- Other trademarks owned by I.D.M. IMMUNO-DESIGNED MOLECULES
- Other trademarks owned by I.D.M. IMMUNO-DESIGNED MOLECULES
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named MEPACT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 22, 2013 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 3, 2010 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Sep 1, 2010 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Oct 16, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 16, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 1, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 16, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 18, 2006 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 25, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 5, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 2, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 1, 2006 | ALIE | ASSIGNED TO LIE | — |
| Feb 8, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 20, 2006 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jan 4, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 4, 2006 | PAPER RECEIVED | — | |
| Jul 6, 2005 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 6, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 3, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 30, 2004 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Dec 30, 2004 | PAPER RECEIVED | — | |
| Dec 8, 2004 | NWAP | NEW APPLICATION ENTERED | — |